In accordance with the Food and Drug Safety Administration's change order for "bisphosphonate" preparation approval (report acceptance) (Drug Safety Information Team No. 2427, effective date 2012.8.30), the precautions for the use of Bonseron tablets have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.